{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T14:53:08Z","timestamp":1792162388606,"version":"4.4.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,4,19]]},"DOI":"10.7759\/cureus.37809","type":"journal-article","created":{"date-parts":[[2023,4,19]],"date-time":"2023-04-19T07:23:44Z","timestamp":1681889024000},"source":"Crossref","is-referenced-by-count":11,"title":["Clinico-Metabolic Profile in Lean Versus Obese Polycystic Ovarian Syndrome Women"],"prefix":"10.7759","author":[{"given":"Nidhi","family":"Makhija","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Surekha","family":"Tayade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shikha","family":"Toshniwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hard","family":"Tilva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1210\/js.2019-00078","article-title":"Polycystic ovary syndrome: pathophysiology, presentation, and treatment with emphasis on adolescent girls","volume":"3","author":"Witchel SF","year":"2019","unstructured":"Witchel SF, Oberfield SE, Pe\u00f1a AS. Polycystic ovary syndrome: pathophysiology, presentation, and treatment with emphasis on adolescent girls. J Endocr Soc. 2019, 3:1545-73. 10.1210\/js.2019-00078","journal-title":"J Endocr Soc"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.4103\/ijmr.IJMR_1937_17","article-title":"Epidemiology, pathogenesis, genetics & management of polycystic ovary syndrome in India","volume":"150","author":"Ganie MA","year":"2019","unstructured":"Ganie MA, Vasudevan V, Wani IA, Baba MS, Arif T, Rashid A. Epidemiology, pathogenesis, genetics & management of polycystic ovary syndrome in India. Indian J Med Res. 2019, 150:333-44. 10.4103\/ijmr.IJMR_1937_17","journal-title":"Indian J Med Res"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-014-0089-2","article-title":"Plasma nesfatin-1 levels are increased in patients with polycystic ovary syndrome","volume":"37","author":"Ademoglu EN","year":"2014","unstructured":"Ademoglu EN, Gorar S, Carl\u0131oglu A, et al.. Plasma nesfatin-1 levels are increased in patients with polycystic ovary syndrome. J Endocrinol Invest. 2014, 37:715-9. 10.1007\/s40618-014-0089-2","journal-title":"J Endocrinol Invest"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1111\/obr.12063","article-title":"The role of nesfatin-1 in the regulation of food intake and body weight: recent developments and future endeavors","volume":"14","author":"Stengel A","year":"2013","unstructured":"Stengel A, Mori M, Tach\u00e9 Y. The role of nesfatin-1 in the regulation of food intake and body weight: recent developments and future endeavors. Obes Rev. 2013, 14:859-70. 10.1111\/obr.12063","journal-title":"Obes Rev"},{"key":"ref5","article-title":"Divergence of melanocortin pathways in the control of food intake and energy expenditure","volume":"14","author":"Balthasar N","year":"2005","unstructured":"Balthasar N, Dalgaard LT, Lee CE, et al.. Divergence of melanocortin pathways in the control of food intake and energy expenditure. Cell. 2005, 14:493-505.","journal-title":"Cell"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1993.tb01744.x","article-title":"The impact of obesity on hyperandrogenism and polycystic ovary syndrome in premenopausal women","volume":"39","author":"Pasquali R","year":"1993","unstructured":"Pasquali R, Casimirri F. The impact of obesity on hyperandrogenism and polycystic ovary syndrome in premenopausal women. Clin Endocrinol (Oxf). 1993, 39:1-16. 10.1111\/j.1365-2265.1993.tb01744.x","journal-title":"Clin Endocrinol (Oxf)"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.00341.2011","article-title":"Transgenic overexpression of intraislet ghrelin does not affect insulin secretion or glucose metabolism in vivo","volume":"302","author":"Bando M","year":"2012","unstructured":"Bando M, Iwakura H, Ariyasu H, et al.. Transgenic overexpression of intraislet ghrelin does not affect insulin secretion or glucose metabolism in vivo. Am J Physiol Endocrinol Metab. 2012, 302:E403-8. 10.1152\/ajpendo.00341.2011","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.2000.tb06230.x","article-title":"The genetics of obesity. Lessons for polycystic ovary syndrome","volume":"900","author":"Legro RS","year":"2000","unstructured":"Legro RS. The genetics of obesity. Lessons for polycystic ovary syndrome. Ann N Y Acad Sci. 2000, 900:193-202. 10.1111\/j.1749-6632.2000.tb06230.x","journal-title":"Ann N Y Acad Sci"},{"key":"ref9","article-title":"Amenorrhea associated with bilateral polycystic ovaries","volume":"14","author":"Stein IF","year":"1935","unstructured":"Stein IF, Leventhal ML. Amenorrhea associated with bilateral polycystic ovaries. Am J Obstet Gynecol. 1935, 14:181-91.","journal-title":"Am J Obstet Gynecol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1093\/hsw\/hlz033","article-title":"Women with polycystic ovary syndrome: a marginalized population in the United States","volume":"45","author":"Sanchez N","year":"2020","unstructured":"Sanchez N. Women with polycystic ovary syndrome: a marginalized population in the United States. Health Soc Work. 2020, 45:40-6. 10.1093\/hsw\/hlz033","journal-title":"Health Soc Work"},{"key":"ref11","article-title":"The prevalence of polycystic ovary syndrome: a brief systematic review","volume":"14","author":"Deswal R","year":"2020","unstructured":"Deswal R, Narwal V, Dang A, Pundir C. The prevalence of polycystic ovary syndrome: a brief systematic review. J Hum Reprod Sci. 2020, 14:261-265.","journal-title":"J Hum Reprod Sci"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.4103%2Fjfmpc.jfmpc_281_18","article-title":"Prolactin and thyroid stimulating hormone affecting the pattern of LH\/FSH secretion in patients with polycystic ovary syndrome: a hospital-based study from North East India","volume":"8","author":"Nath C","year":"2019","unstructured":"Nath C, Barman B, Das A, et al.. Prolactin and thyroid stimulating hormone affecting the pattern of LH\/FSH secretion in patients with polycystic ovary syndrome: a hospital-based study from North East India. J Family Med Prim Care. 2019, 8:256-259. 10.4103%2Fjfmpc.jfmpc_281_18","journal-title":"J Family Med Prim Care"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.83.8.5054","article-title":"A fasting glucose to insulin ratio is a useful measure of insulin sensitivity in women with polycystic ovary syndrome","volume":"83","author":"Legro RS","year":"1998","unstructured":"Legro RS, Finegood D, Dunaif A. A fasting glucose to insulin ratio is a useful measure of insulin sensitivity in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 1998, 83:2694-98. 10.1210\/jcem.83.8.5054","journal-title":"J Clin Endocrinol Metab"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.4103\/jhrs.JHRS_108_16","article-title":"Correlations between anthropometry and lipid profile in women with PCOS","volume":"10","author":"Kiranmayee D","year":"2017","unstructured":"Kiranmayee D, Kavya K, Himabindu Y, Sriharibabu M, Madhuri GL, Venu S. Correlations between anthropometry and lipid profile in women with PCOS. J Hum Reprod Sci. 2017, 10:167-72. 10.4103\/jhrs.JHRS_108_16","journal-title":"J Hum Reprod Sci"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1111\/cen.13968","article-title":"Effects of empagliflozin on metabolic parameters in polycystic ovary syndrome: a randomized controlled study","volume":"90","author":"Javed Z","year":"2019","unstructured":"Javed Z, Papageorgiou M, Deshmukh H, et al.. Effects of empagliflozin on metabolic parameters in polycystic ovary syndrome: a randomized controlled study. Clin Endocrinol (Oxf). 2019, 90:805-13. 10.1111\/cen.13968","journal-title":"Clin Endocrinol (Oxf)"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2003.10.004","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)","volume":"18","author":"The Rotterdam ESHRE\/ASRM-sponsored PCOS consensus workshop group","year":"2004","unstructured":"The Rotterdam ESHRE\/ASRM-sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Fertil Steril. 2004, 18:19-25. 10.1016\/j.fertnstert.2003.10.004","journal-title":"Fertil Steril"},{"key":"ref17","article-title":"Serum Nesfatin-1 levels in experimentally induced polycystic ovary in lean and obese Albino rats","volume":"14","author":"Khalil GN","year":"2016","unstructured":"Khalil GN, Albiomy KA. Serum Nesfatin-1 levels in experimentally induced polycystic ovary in lean and obese Albino rats. Al-Azhar Med J. 2016, 14:885-900.","journal-title":"Al-Azhar Med J"},{"key":"ref18","article-title":"Polycystic ovary syndrome: a review of treatment options with a focus on pharmacological approaches","volume":"38","author":"Ndefo UA","year":"2013","unstructured":"Ndefo UA, Eaton A, Green MR. Polycystic ovary syndrome: a review of treatment options with a focus on pharmacological approaches. P T. 2013, 38:336-55.","journal-title":"P T"},{"key":"ref19","article-title":"Copeptin and nesfatin-1 are interrelated biomarkers with roles in the pathogenesis of insulin resistance in Chinese children with obesity","volume":"14","author":"Yin C","year":"2020","unstructured":"Yin C, Liu W, Xu E, et al.. Copeptin and nesfatin-1 are interrelated biomarkers with roles in the pathogenesis of insulin resistance in Chinese children with obesity. Ann Nutr Metab. 2020, 14:223-32.","journal-title":"Ann Nutr Metab"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.14715\/cmb\/2021.67.5.8","article-title":"Expression of serum PSA, nesfatin-1, and AMH in patients with polycystic ovary syndrome","volume":"67","author":"Wang Y","year":"2022","unstructured":"Wang Y, Ma X, Luo J, Wang X, Han L. Expression of serum PSA, nesfatin-1, and AMH in patients with polycystic ovary syndrome. Cell Mol Biol (Noisy-le-grand). 2022, 67:57-63. 10.14715\/cmb\/2021.67.5.8","journal-title":"Cell Mol Biol (Noisy-le-grand)"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph19042099","article-title":"Review of novel potential insulin resistance biomarkers in PCOS patients-the debate is still open","volume":"19","author":"Kruszewska J","year":"2022","unstructured":"Kruszewska J, Laudy-Wiaderny H, Kunicki M. Review of novel potential insulin resistance biomarkers in PCOS patients-the debate is still open. Int J Environ Res Public Health. 2022, 19:2099-2109. 10.3390\/ijerph19042099","journal-title":"Int J Environ Res Public Health"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2010.217","article-title":"Polycystic ovary syndrome: etiology, pathogenesis and diagnosis","volume":"7","author":"Goodarzi MO","year":"2011","unstructured":"Goodarzi MO, Dumesic DA, Chazenbalk G, Azziz R. Polycystic ovary syndrome: etiology, pathogenesis and diagnosis. Nat Rev Endocrinol. 2011, 7:219-31. 10.1038\/nrendo.2010.217","journal-title":"Nat Rev Endocrinol"},{"key":"ref23","article-title":"Correlation of skin changes with hormonal changes in polycystic ovarian syndrome: a cross-sectional study clinical study","volume":"14","author":"Chandravathi P","year":"2015","unstructured":"Chandravathi P, Sindhu P, Naidu Ks, Gowri Bv. Correlation of skin changes with hormonal changes in polycystic ovarian syndrome: a cross-sectional study clinical study. Indian J Dermatol. 2015, 14:60-64.","journal-title":"Indian J Dermatol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1111\/cen.12092","article-title":"The role of obesity and type 2 diabetes mellitus in the development of male obesity-associated secondary hypogonadism","volume":"78","author":"Saboor Aftab SA","year":"2013","unstructured":"Saboor Aftab SA, Kumar S, Barber TM. The role of obesity and type 2 diabetes mellitus in the development of male obesity-associated secondary hypogonadism. Clin Endocrinol (Oxf). 2013, 78:330-7. 10.1111\/cen.12092","journal-title":"Clin Endocrinol (Oxf)"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a009191","article-title":"Insulin receptor signaling in normal and insulin-resistant states","volume":"6","author":"Boucher J","year":"2014","unstructured":"Boucher J, Kleinridders A, Kahn CR. Insulin receptor signaling in normal and insulin-resistant states. Cold Spring Harb Perspect Biol. 2014, 6:10.1101\/cshperspect.a009191","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"ref26","article-title":"The association between serum nesfatin-1 level and BMI in Iraqi patients with polycystic ovary syndrome (PCOS)","volume":"15","author":"Ali EA","year":"2021","unstructured":"Ali EA, Ahmed AL, Satha M, Khateeb AL. The association between serum nesfatin-1 level and BMI in Iraqi patients with polycystic ovary syndrome (PCOS). Health Res Policy Syst. 2021, 15:1490-1495.","journal-title":"Health Res Policy Syst"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.18502\/jri.v23i3.10006","article-title":"Nesfatin-1, dopamine, and NADPH levels in infertile women with polycystic ovary syndrome: is there a relationship between their levels and metabolic and hormonal variables","volume":"23","author":"Hamed EA","year":"2022","unstructured":"Hamed EA, Sayyed HG, Abbas AM, Gaber MM, Aleem HM. Nesfatin-1, dopamine, and NADPH levels in infertile women with polycystic ovary syndrome: is there a relationship between their levels and metabolic and hormonal variables. J Reprod Infertil. 2022, 23:160-8. 10.18502\/jri.v23i3.10006","journal-title":"J Reprod Infertil"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.5114%2Fpm.2020.95293","article-title":"Elevated and diagnostic androgens of polycystic ovary syndrome","volume":"14","author":"Abdelazim I","year":"2020","unstructured":"Abdelazim I, Alanwar A, AbuFaza M, et al.. Elevated and diagnostic androgens of polycystic ovary syndrome. Prz Menopauzalny. 2020, 14:1-5. 10.5114%2Fpm.2020.95293","journal-title":"Prz Menopauzalny"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2003-032046","article-title":"The prevalence and features of the polycystic ovary syndrome in an unselected population","volume":"89","author":"Azziz R","year":"2004","unstructured":"Azziz R, Woods KS, Reyna R, Key TJ, Knochenhauer ES, Yildiz BO. The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab. 2004, 89:2745-9. 10.1210\/jc.2003-032046","journal-title":"J Clin Endocrinol Metab"},{"key":"ref30","article-title":"Polycystic ovary syndrome: syndrome XX?","volume":"14","author":"Sam S","year":"2003","unstructured":"Sam S, Dunaif A. Polycystic ovary syndrome: syndrome XX?. Trends Endocrinol Metab. 2003, 14:365-70.","journal-title":"Trends Endocrinol Metab"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(05)64894-5","article-title":"Insulin resistance syndrome and childhood social conditions","volume":"25","author":"Davey Smith G","year":"1997","unstructured":"Davey Smith G, Hart C. Insulin resistance syndrome and childhood social conditions. Lancet. 1997, 25:284-5. 10.1016\/s0140-6736(05)64894-5","journal-title":"Lancet"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.21203\/rs.3.rs-1630403\/v1","article-title":"Correlation of serum nesfatin 1 level with metabolic and clinical parameters in Indian women with and without polycystic ovarian syndrome","volume":"1","author":"Faeza F","year":"2022","unstructured":"Faeza F, Pikee S, Anju J. Correlation of serum nesfatin 1 level with metabolic and clinical parameters in Indian women with and without polycystic ovarian syndrome. Res Sq. 2022, 1:1-8. 10.21203\/rs.3.rs-1630403\/v1","journal-title":"Res Sq"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.4274\/tjod.galenos.2021.39024","article-title":"DLK1 and Nesfatin-1 levels and the relationship with metabolic parameters in polycystic ovary syndrome: prospective, controlled study","volume":"18","author":"Demir \u00c7altekin M","year":"2021","unstructured":"Demir \u00c7altekin M, Caniklio\u011flu A, Eris Yal\u00e7\u0131n S, Aydo\u011fan K\u0131rm\u0131z\u0131 D, Baser E, Yalva\u00e7 ES. DLK1 and Nesfatin-1 levels and the relationship with metabolic parameters in polycystic ovary syndrome: prospective, controlled study. Turk J Obstet Gynecol. 2021, 18:124-30. 10.4274\/tjod.galenos.2021.39024","journal-title":"Turk J Obstet Gynecol"},{"key":"ref34","article-title":"Cutaneous manifestations and hormonal changes among polycystic ovary syndrome patients at a tertiary care center","volume":"13","author":"Aljefri YE","year":"2021","unstructured":"Aljefri YE, Alahmadi RA, Alajmi RS, et al.. Cutaneous manifestations and hormonal changes among polycystic ovary syndrome patients at a tertiary care center. Cureus. 2021, 13:1-11.","journal-title":"Cureus"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.4103%2Fidoj.IDOJ_249_17","article-title":"Update on management of polycystic ovarian syndrome for dermatologists","volume":"14","author":"Gainder S","year":"2019","unstructured":"Gainder S, Sharma B. Update on management of polycystic ovarian syndrome for dermatologists. Indian Dermatol Online J. 2019, 14:97-100. 10.4103%2Fidoj.IDOJ_249_17","journal-title":"Indian Dermatol Online J"},{"key":"ref36","article-title":"Polycystic ovary syndrome and acne","volume":"15","author":"Chuan SS","year":"2010","unstructured":"Chuan SS, Chang RJ. Polycystic ovary syndrome and acne. Skin Therapy Lett. 2010, 15:1-4.","journal-title":"Skin Therapy Lett"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2458-9-88","article-title":"The incidence of co-morbidities related to obesity and overweight: a systematic review and meta-analysis","volume":"9","author":"Guh DP","year":"2009","unstructured":"Guh DP, Zhang W, Bansback N, Amarsi Z, Birmingham CL, Anis AH. The incidence of co-morbidities related to obesity and overweight: a systematic review and meta-analysis. BMC Public Health. 2009, 9:88. 10.1186\/1471-2458-9-88","journal-title":"BMC Public Health"},{"key":"ref38","doi-asserted-by":"crossref","DOI":"10.5812\/hepatmon.23235","article-title":"Are women with polycystic ovarian syndrome at a high risk of non-alcoholic fatty liver disease; a meta-analysis","volume":"14","author":"Ramezani Binabaj M","year":"2014","unstructured":"Ramezani Binabaj M, Motalebi M, Karimi-Sari H, Rezaee Zavareh MS, Alavian SM. Are women with polycystic ovarian syndrome at a high risk of non-alcoholic fatty liver disease; a meta-analysis. Hepat Mon. 2014, 14:14-16.","journal-title":"Hepat Mon"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/140690-clinico-metabolic-profile-in-lean-versus-obese-polycystic-ovarian-syndrome-women","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:55:34Z","timestamp":1707508534000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/140690-clinico-metabolic-profile-in-lean-versus-obese-polycystic-ovarian-syndrome-women"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,19]]},"references-count":38,"URL":"https:\/\/doi.org\/10.7759\/cureus.37809","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4,19]]}}}